Valls A, Grañena A, Carreras E, Ferrer E, Algara M
Servicio de Radioterapia, Hospital de la Esperanza, Barcelona, Spain.
Bull Cancer. 1989;76(8):797-804.
The usefulness of total body irradiation (TBI) plus chemotherapy as a preparative regimen prior to bone marrow transplantation has been widely documented. However, the procedure can be highly toxic. Fractionated and low dose rate TBI has been said to enhance therapeutic ratio by increasing normal tissue tolerance and increasing leukemic cell kill. We report here the acute toxic effects and preliminary results on 2 consecutively groups of patients, treated with bone marrow transplantation (BMT) for leukemia or multiple myeloma, and conditioned by 2 TBI regimens. Group A patients received 10 Gy-Co-60 single dose of TBI plus 120 mg/kg of cyclophosphamide over a period of 2 days (8 Gy lungs). Group B received 12 Gy Co-60 of TBI in 6 fractions (2/day), (8 Gy lungs) plus 120 mg/kg of cyclophosphamide over a period of 3 days. The acute toxic effects recorded were similar in both groups. Only a 40% vs 0% (P = 0.02) incidence of parotiditis in groups A and B favors fractionation. Other results obtained to date are as follows: an incidence of interstitial pneumonitis of 39% and 31% (ns); relapses of 10% and 20% (ns), and mortality of 55% and 60% for each group respectively. An interesting finding was that IP was associated with acute grade II-IV graft vs host disease in 87% and 100% of cases of group A and B, respectively. We conclude that fractionated TBI is at least as effective as single dose TBI as a conditioning regimen; however, only randomized trials would allow definitive conclusions.
全身照射(TBI)联合化疗作为骨髓移植前的预处理方案,其有效性已得到广泛记载。然而,该 procedure 毒性可能很大。据说分次低剂量率 TBI 通过提高正常组织耐受性和增加白血病细胞杀伤来提高治疗比率。我们在此报告连续两组接受白血病或多发性骨髓瘤骨髓移植(BMT)并采用两种 TBI 方案进行预处理的患者的急性毒性作用和初步结果。A 组患者接受 10Gy - Co - 60 单次 TBI 照射,同时在 2 天内给予 120mg/kg 环磷酰胺(肺部照射剂量 8Gy)。B 组接受 12Gy Co - 60 分 6 次照射(每天 2 次)(肺部照射剂量 8Gy),同时在 3 天内给予 120mg/kg 环磷酰胺。两组记录的急性毒性作用相似。仅 A 组和 B 组的腮腺炎发生率分别为 40%和 0%(P = 0.02),这表明分次照射更具优势。迄今为止获得的其他结果如下:两组间质性肺炎发生率分别为 39%和 31%(无显著性差异);复发率分别为 10%和 20%(无显著性差异),每组死亡率分别为 55%和 60%。一个有趣的发现是 A 组和 B 组分别有 87%和 100%的病例中,间质性肺炎与急性 II - IV 级移植物抗宿主病相关。我们得出结论,分次 TBI 作为预处理方案至少与单次剂量 TBI 一样有效;然而,只有随机试验才能得出明确结论。